The company started in April 2018 with preclinical analyses of nucleotide sugars for a start-up pharmaceutical company in San Francisco (US), to aim for the first medicine for the rare disorder PMM2-CDG, a congenital disorder of glycosylation.
During the current pandemic crisis, we still continue and work on ongoing and new projects according to our high quality standards that you are used to.
New: we offer hand sanitizer spray based on the WHO recipe. It is made from biological ingredients and suitable for children. Read more...